Loss of heterozygosity in somatic cells of the mouse: An important step in cancer initiation?

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 473, Issue 1, 2001, Pages 23-36

  Wijnhoven, Susan W P ^a   Kool, Hanneke J M ^b   Van Teijlingen, Corrie M M ^a   Van Zealand, Albert A ^a,c   Vrieling, Harry ^a,c  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^c JA Cohen Institute Interuniversity Research Institute for Radiopathology and Radiation Protection   (Netherlands)

Author keywords

Aprt; Carcinogens; Loss of heterozygosity (LOH); Mutagenesis; Transgenic mouse models

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; AUTOSOME; CARCINOGENESIS; CELL VIABILITY; FAMILIAL CANCER; GENE LOCUS; HETEROZYGOSITY LOSS; MARKER GENE; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVIEW; SOMATIC CELL; SOMATIC CELL GENETICS; TUMOR SUPPRESSOR GENE;

MUS MUSCULUS;

EID: 0035945687     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0027-5107(00)00163-9     Document Type: Article

References (57)

1. Antioncogenes and human cancer
2. Lessons from hereditary colorectal cancer
3. p53, the cellular gatekeeper for growth and division
4. A genetic model for colorectal tumorigenesis
5. Homozygous deficiency at autosomal locus Aprt in human somatic cells in vivo induced by two different mechanisms
6. Diagnosis of heterozygous states for adenine phosphoribosyltransferase deficiency based on detection of in vivo somatic mutants in blood T-cells: Application to screening of heterozygotes
7. APRT: A versatile in vivo resident reporter of local mutation and loss of heterozygosity
8. High frequency in vivo loss of heterozygosity is primarily a consequence of mitotic recombination
9. Somatic mutations at a heterozygous autosomal locus in human cells occur more frequently by allele loss than by intragenic structural alterations
10. Molecular genetic analysis of recessive mutations at a heterozygous autosomal locus in human cells
11. A comparison of mutation induction at the Tk and Hprt loci in human lymphoblastoid cells: Quantitative differences are due to an additional class of mutations at the autosomal tk locus
12. Reduction to homozygosity is the predominant spontaneous mutational events in cultured human lymphoblastoid cells
13. Heritable alterations at the adenine phosphoribosyltransferase (APRT) locus in human lymphoblastoid cell lines
14. Different cytotoxic and mutagenic responses induced by X-rays in two human lymphoblastoid cell lines derived from a single donor
15. Molecular mechanisms of spontaneous and induced loss of heterozygosity in human cells in vitro
16. Allelic losses in mutations at the Aprt locus of human lymphoblastoid cells
17. Evidence for high-frequency allele loss at the Aprt locus in TK6 human lymphoblasts
18. Genetic instability on chromosome 16 in a human B lymphoblastoid cell line
19. Isolation of an APRT heterozygote from TK6 human lymphoblasts: Predominance of multi-locus loss of heterozygosity among spontaneous Aprt(-) mutants
20. Analysis of germline and in vivo somatic mutations in the human adenine phosphoribosyltransferase gene: Mutational hot spots at the intron 4 splice donor site and at codon, 87
21. Intervention of somatic mutational events in vivo by a germline defect at the adenine phosphoribosyltransferase locus
22. Development of a cloning assay with high cloning efficiency to detect induction of 6-thioguanine-resistant lymphocytes in spleen of adult mice following in vivo inhalation exposure to 1,3-butadiene
23. Adenine phosphoribosyltransferase-deficient mice develop 2,8-dihydroxyadenine nephrolithiasis
24. Mice with adenine phosphoribosyltransferase deficiency develop fatal 2,8-dihydroxyadenine lithiasis
25. Determination of spontaneous loss of heterozygosity mutations in Aprt heterozygous mice
26. Tk(+/-) mouse model for detecting in vivo mutation in an endogenous, autosomal gene
27. In vivo loss of heterozygosity in T-cells of B6C3F1 Aprt(+/-) mice
28. Mitotic recombination produces the majority of recessive fibroblast variants in heterozygous mice
29. Molecular analysis of in vivo mutations induced by N-ethyl-N-nitrosourea in the autosomal Tk and the X-linked Hprt genes of mouse lymphocytes
30. Database of mouse strains carrying targeted mutations in genes affecting cellular responses to DNA damage, Version 4
31. Solid tissues removed from ATM homozygous deficient mice do not exhibit a mutator phenotype for second-step autosomal mutations
32. Chromosome instability contributes to loss of heterozygosity in mice lacking p53
33. Carcinogen-induced loss of heterozygosity at the Aprt locus in somatic cells of the mouse
34. +/- mice
35. Inhibitors of DNA synthesis induce sister chromatid exchanges at the early S-phase of the cell cycle
36. Heterozygous Aprt mouse model: Detection and study of a broad range of autosomal somatic mutations in vivo
37. Inactivation of the mouse Msh2 gene results in mismatch repair deficiency, methylation tolerance, hyperrecombination, and predisposition to cancer
38. 6-alkylguanine and N-alkylpurines to the formation of sister chromatid exchanges, chromosomal aberrations, and gene mutations: New insights gained from studies of genetically engineered mammalian cell lines
39. 6-methylguanine in Mex(-), Mex(+) and methylation-tolerant mismatch repair compromised cells: Facts and models
40. Alkylpurine-DNA-N-glycosylase knock-out mice show increased susceptibility to induction of mutations by methyl methanesulfonate
41. Transgenic systems in studies on genotoxicity of alkylating agents: Critical lesions, thresholds and defence mechanisms
42. The realtion between reaction kinetics and mutagenic action of mono-functional alkylating agents in higher eukaryotic systems. I. Recessive lethal mutations and translocations in Drosophila
43. Nucleophilic selectivity of alkylating agents and their hypermutability in Drosophila as predictors of carcinogenic potency in rodents
44. Effects of carcinogenic agents upon different mechanisms for intragenic recombination in mammalian cells
45. Homologous and non-homologous recombination differently affect DNA damage repair in mice
46. International commission for protection against environmental mutagens and carcinogens. Mutagenicity and carcinogenicity of topoisomerase-interactive agents
47. Etoposide (VP-16): Cytogenetic studies in mice
48. Mutation frequency and spectrum in lymphocytes of small cell lung cancer patients receiving etoposide chemotherapy
49. The double-strand-break repair model for recombination
50. Loss of heterozygosity induced by a chromosomal double-strand break
51. LOH and mitotic recombination
52. Sister chromatid gene conversion is a prominent double-strand break repair pathway in mammalian cells
53. Cytological detection of mutagen-carcinogen exposure by sister chromatid exchange
54. Sister chromatid exchanges - A sensitive assay of agents damaging human chromosomes
55. Homologous recombination is required for the viability of rad27 mutants
56. Replication fork pausing and recombination or "gimme a break"
57. Replication and recombination intersect